Embryo Financial Services Private Limited

Embryo Financial Services Private Limited - financial services in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U67190MH1994PTC083846 Incorporated 19 December 1994 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company financial services
Data last updated
Revenue · FY 2025
₹11.03 Lakh
▼ 8% YoY
Net profit · FY 2025
₹70,152
Net margin 6.4%
EBITDA · FY 2025
₹3.39 Lakh
EBITDA margin 30.8%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹15 Lakh
Issued & subscribed
Company age
32 yrs
Est. 1994
Directors on board
3
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Embryo Financial Services Private Limited

Data last updated:

Embryo Financial Services Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the financial brokerage segment of the financial services sector. It was incorporated on 19 December 1994 and has been in existence for over 32 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U67190MH1994PTC083846.

The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Ankita Maheshwari Mukesh (Managing Director) and Deepika Krishna Gopal Maheshwari (Managing Director).

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹11.03 Lakh, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹70,152 (net margin 6.4%) and EBITDA of ₹3.39 Lakh (EBITDA margin 30.8%). Revenue has declined at a compounded annual rate (CAGR) of 42% over three years and 7% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U67190MH1994PTC083846
Registration Number 083846
Incorporation Date 19 December 1994
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Embryo Financial Services Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    606 Manish Chambers Premises Co Op. Soc. Ltd, Sonawala Road Opp. Karan Palace Hotel, Mumbai, Maharashtra, India – 400063
  • Industry
    Financial Services, Financial Brokerage, Advisory, Consultancy

To see the full contact details of Embryo Financial Services Private Limited, buy the company report.

Comprehensive company report
Embryo Financial Services Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Embryo Financial Services is financial and insurance activities. In detail, this covers financial service activities, except insurance and pension funding.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
KFinancial and insurance activities64Financial service activities, except insurance and pension funding

To see the full business activity and turnover split of Embryo Financial Services Private Limited, buy the company report.

Financials of Embryo Financial Services Private Limited

FY 2025 filings available

Embryo Financial Services Private Limited reported revenue of ₹11.03 Lakh (down 8% YoY) for FY 2025.

Revenue · FY 2025
₹11.03 Lakh ▼ 8%
Net profit · FY 2025
₹70,152 margin 6.4%
EBITDA · FY 2025
₹3.39 Lakh margin 30.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 8%
3 years · compounded
▼ 42%
5 years · compounded
▼ 7%
EBITDA CAGR growth
1 year
▲ 4%
3 years · compounded
▼ 57%
5 years · compounded
▲ 1%

Revenue has declined at a compounded annual rate (CAGR) of 7% over five years, including a 8% fall in the latest year. EBITDA rose 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹3.39 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹70,152
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin30.8%
Net Profit Margin6.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Embryo Financial Services Private Limited, buy the company report.

Board of directors of Embryo Financial Services Private Limited

Embryo Financial Services has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Ankita Maheshwari MukeshManaging Director20 Nov 201312 Years 11 MonthsCurrent
Mukesh Ratanlal MaheshwariDirector20 Jun 20233 Years 4 MonthsCurrent
Deepika Krishna Gopal MaheshwariManaging Director20 Nov 201312 Years 11 MonthsCurrent

Peer comparison

Embryo Financial Services Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (financial service activities, except insurance and pension funding), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Genius Growth Advisors Private Limited₹11.3 Lakh (FY 2025)-32.0%Mumbai, Maharashtra, India
Onesto Wealth Private Limited₹11.21 Lakh (FY 2025)-21.0%Faridabad, Haryana, India
Katariya Marketing and Financial Services Private Limited₹11.15 Lakh (FY 2024)-2.0%Ahmednagar, Maharashtra, India
Citrine Holding Private Limited₹11.12 Lakh (FY 2025)102.0%Dindori, Maharashtra, India
Montego Finvestrade India Private Limited₹11.03 Lakh (FY 2025)9.0%Pune, Maharashtra, India
Embryo Financial Services Private Limitedthis company₹11.03 Lakh (FY 2025)₹70,1526.4%-8.0%Mumbai, Maharashtra, India
Daksfirst Advisors Private Limited₹11 Lakh (FY 2025)-55.0%Mumbai, Maharashtra, India
Navapesa Micro Care Foundation₹10.97 Lakh (FY 2025)2158.0%New Delhi, Delhi, India
Manorath Nidhi Limited₹10.86 Lakh (FY 2025)44.0%Hubli, Karnataka, India
Treatise Investment Services Private Limited₹10.86 Lakh (FY 2025)-36.0%Delhi, India
DVS Srikara Fin & Infra Private Limited₹10.84 Lakh (FY 2024)-73.0%Vijayawada, Andhra Pradesh, India

To see the full peer comparison of Embryo Financial Services Private Limited, buy the company report.

Auditor

Embryo Financial Services Private Limited is audited by MONIKA JAIN & CO. for the financial year 2017.

Auditor firmFinancial yearFirm registration number
MONIKA JAIN & CO.FY 2017130708W

Shareholding

The shareholding of Embryo Financial Services Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Embryo Financial Services Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Embryo Financial Services Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Embryo Financial Services Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Embryo Financial Services Private Limited has 6 board changes on record since 2013: 3 appointments and 3 cessations. The latest: Mukesh Ratanlal Maheshwari was appointed as Director on 20 Jun 2023.

AGM
Embryo Financial Services Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Embryo Financial Services Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Appointed
Mukesh Ratanlal Maheshwari was appointed as Director.
Ceased
Krishna Gopal Ratanlal Maheshwari ceased to be Director.
Ceased
Mukesh Ratanlal Maheshwari ceased to be Director.
Ceased
Ratanlal Jankilal Jaitlia ceased to be Director.
Appointed
Ankita Maheshwari Mukesh was appointed as Managing Director.
Appointed
Deepika Krishna Gopal Maheshwari was appointed as Managing Director.
Incorporation
19 Dec 1994
Embryo Financial Services Private Limited was registered on 19 Dec 1994 with Roc Mumbai I & aged 31 years 10 months as per MCA records.

Frequently asked questions

Embryo Financial Services is an active private limited company based in Mumbai, Maharashtra, India. The company works in financial brokerage, within the financial services industry. It was incorporated on 19 December 1994 (32+ years old) and is registered under CIN U67190MH1994PTC083846.

Embryo Financial Services has 3 current directors:

The latest financial statements of Embryo Financial Services on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The CIN (Corporate Identification Number) of Embryo Financial Services is U67190MH1994PTC083846. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Embryo Financial Services was incorporated on 19 December 1994, making it 32+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Embryo Financial Services by revenue are Genius Growth Advisors Private Limited, Onesto Wealth Private Limited, Katariya Marketing and Financial Services Private Limited, Citrine Holding Private Limited, Montego Finvestrade India Private Limited and 5 more, all in the same principal business activity (financial service activities, except insurance and pension funding).

Mukesh Ratanlal Maheshwari was appointed as Director on 20 Jun 2023. Krishna Gopal Ratanlal Maheshwari ceased to be Director on 25 Nov 2013. Mukesh Ratanlal Maheshwari ceased to be Director on 25 Nov 2013. Embryo Financial Services has 6 board changes on record in total.

The registered office of Embryo Financial Services is at 606 Manish Chambers Premises Co Op. Soc. Ltd, Sonawala Road Opp. Karan Palace Hotel, Mumbai, Maharashtra, India – 400063.

Embryo Financial Services operates in the financial services industry, in the financial brokerage segment.

The compliance status of Embryo Financial Services is compliant as of 18 August 2026. The company is actively filing with the Registrar of Companies.

Embryo Financial Services can be reached at its registered office: 606 Manish Chambers Premises Co Op. Soc. Ltd, Sonawala Road Opp. Karan Palace Hotel, Mumbai, Maharashtra, India – 400063.